CN Stock MarketDetailed Quotes
300158 Shanxi Zhendong Pharmaceutical
- 4.91
- -0.13-2.58%
Market Closed Nov 15 15:00 CST
4.94BMarket Cap-1636666P/E (TTM)
5.11High4.91Low269.25KlotVolume5.00Open5.04Pre Close135.11MTurnover2.69%Turnover RatioLossP/E (Static)1.01BShares8.4752wk High0.96P/B4.92BFloat Cap3.1352wk Low6.05Limit Up1.00BShs Float12.96Historical High4.03Limit Down3.97%Amplitude0.48Historical Low--Dividend TTM5.02Avg Price155.48KlotAsk--Div YieldTTM100Lot Size106.44KlotBid
Shanxi Zhendong Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -13.98%2.48B | -12.74%1.69B | -10.27%800.53M | 0.27%3.89B | 2.48%2.88B | 12.96%1.94B | 0.40%892.12M | -28.85%3.88B | -33.78%2.81B | -34.15%1.72B |
| Refunds of taxes and levies | -32.61%18.11M | -43.04%13.49M | -56.70%6.49M | 5.26%61.03M | -53.49%26.87M | -25.19%23.69M | -49.16%15M | 30.46%57.98M | 1,201.29%57.78M | 613.29%31.67M |
| Cash received relating to other operating activities | 87.58%37.32M | 55.80%26.16M | 26.03%10.89M | 69.72%51.58M | 128.68%19.9M | 148.99%16.79M | 3.96%8.64M | -20.16%30.39M | -90.99%8.7M | -86.03%6.74M |
| Cash inflows from operating activities | -13.46%2.54B | -12.52%1.73B | -10.68%817.91M | 0.87%4B | 1.74%2.93B | 12.80%1.98B | -1.15%915.76M | -28.32%3.97B | -33.78%2.88B | -34.01%1.76B |
| Goods services cash paid | -18.25%1.15B | -14.06%816.33M | -20.23%424.97M | 21.55%1.95B | 16.60%1.41B | 38.60%949.83M | 58.40%532.74M | -5.76%1.6B | -9.83%1.21B | -25.87%685.31M |
| Staff behalf paid | 25.28%365.32M | 7.57%243.73M | 9.65%113.06M | 12.24%468.71M | -5.44%291.6M | 13.33%226.57M | 6.08%103.11M | -7.14%417.6M | -12.43%308.39M | -12.83%199.91M |
| All taxes paid | -37.28%138.55M | -35.69%100.4M | -37.18%49.84M | 2.50%275.91M | 15.56%220.91M | 15.79%156.1M | 12.63%79.34M | -49.85%269.18M | -55.65%191.15M | -58.43%134.82M |
| Cash paid relating to other operating activities | -19.58%987.96M | -20.12%604.9M | -39.84%253.92M | -2.10%1.56B | -2.84%1.23B | -0.07%757.26M | 20.22%422.07M | -37.91%1.59B | -36.48%1.26B | -37.91%757.75M |
| Cash outflows from operating activities | -16.08%2.65B | -15.52%1.77B | -25.98%841.79M | 9.53%4.25B | 5.98%3.15B | 17.55%2.09B | 33.00%1.14B | -26.08%3.88B | -27.74%2.98B | -34.12%1.78B |
| Net cash flows from operating activities | 50.38%-110.77M | 70.74%-31.54M | 89.22%-23.87M | -388.70%-249.17M | -134.23%-223.26M | -421.48%-107.79M | -410.50%-221.51M | -69.66%86.31M | -141.09%-95.32M | 42.51%-20.67M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -20.34%5.01B | -5.28%3.76B | 3.08%2.17B | -54.80%8.84B | -63.41%6.29B | -73.38%3.97B | -65.35%2.11B | 342.22%19.55B | 3,433.08%17.2B | 4,312.87%14.93B |
| Cash received from returns on investments | 13.72%35.97M | 26.08%28.98M | 19.22%16.63M | -23.85%59.22M | -54.62%31.63M | -61.41%22.99M | 204.86%13.95M | 3,369.18%77.77M | 5,579.71%69.71M | 5,209.99%59.57M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,233.35%8.83M | --6.6M | 2,545.39%5.05M | ---- | --662.5K | ---- | --191K | --1.09M | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | --1.03M | --1.03M | ---- | ---- | ---- | ---- | ---- | ---- | --164.68M | --164.68M |
| Cash inflows from investing activities | -20.02%5.06B | -4.91%3.8B | 3.42%2.19B | -54.68%8.9B | -63.71%6.33B | -73.62%4B | -65.14%2.12B | 109.21%19.63B | 3,472.22%17.44B | 4,364.35%15.15B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 227.20%232.14M | 192.10%141.25M | 2,172.90%71.85M | -20.30%116.21M | -1.22%70.95M | -4.85%48.36M | -42.96%3.16M | -3.86%145.81M | -19.89%71.83M | 18.87%50.82M |
| Cash paid to acquire investments | -11.04%5B | 8.05%3.8B | 23.11%2.16B | -51.39%8.31B | -60.37%5.62B | -70.93%3.52B | -73.32%1.76B | 92.37%17.09B | 2,536.15%14.19B | 3,344.51%12.11B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.98M | --430.68M | --430.68M |
| Cash outflows from investing activities | -8.07%5.23B | 10.54%3.95B | 26.97%2.24B | -51.14%8.42B | -61.24%5.69B | -71.66%3.57B | -73.30%1.76B | 90.81%17.24B | 2,236.89%14.69B | 3,093.22%12.6B |
| Net cash flows from investing activities | -127.44%-173.87M | -133.78%-144.62M | -112.22%-43.84M | -80.23%472.84M | -76.93%633.51M | -83.26%428.11M | 169.86%358.66M | 585.69%2.39B | 2,054.81%2.75B | 4,747.47%2.56B |
| Financing cash flow | ||||||||||
| Cash from borrowing | --9.31M | --13.99M | --3.56M | -99.88%97.8K | ---- | ---- | ---- | -81.16%80M | -75.36%80M | -53.68%80M |
| Cash received relating to other financing activities | -12.05%61.07M | -33.39%32.41M | -32.95%20.12M | -90.62%86.41M | -92.08%69.43M | -92.28%48.67M | --30.01M | 3,053.40%921.62M | 3,267.94%876.63M | 3,980.11%630.77M |
| Cash inflows from financing activities | 1.36%70.38M | -4.66%46.4M | -21.07%23.68M | -91.36%86.51M | -92.74%69.43M | -93.15%48.67M | 200.06%30.01M | 120.66%1B | 172.79%956.63M | 277.75%710.77M |
| Borrowing repayment | 151.00%50.2M | 151.00%50.2M | ---- | -94.47%21M | -93.86%20M | -74.57%20M | ---- | -39.80%379.55M | -14.85%325.65M | -70.76%78.65M |
| Dividend interest payment | -49.35%505.77K | -37.82%421.47K | -39.17%227.19K | -99.96%1.22M | -99.97%998.65K | -99.98%677.8K | -89.46%373.46K | 1,328.18%2.79B | 1,465.60%2.94B | 3,353.38%2.78B |
| Cash payments relating to other financing activities | -23.97%155.28M | -23.47%141.35M | -23.68%107.31M | -74.36%208.85M | -43.83%204.24M | -30.45%184.69M | 875.64%140.6M | 5,408.39%814.53M | 2,800.09%363.58M | 1,275.25%265.54M |
| Cash outflows from financing activities | -8.55%205.98M | -6.52%191.97M | -23.72%107.54M | -94.19%231.08M | -93.80%225.24M | -93.43%205.36M | 339.13%140.98M | 373.65%3.98B | 522.86%3.63B | 747.48%3.13B |
| Net cash flows from financing activities | 12.97%-135.61M | 7.10%-145.57M | 24.44%-83.85M | 95.15%-144.57M | 94.17%-155.81M | 93.51%-156.7M | -402.04%-110.97M | -670.79%-2.98B | -1,051.64%-2.67B | -1,236.52%-2.42B |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -265.17%-420.25M | -296.63%-321.73M | -678.96%-151.57M | 115.81%79.1M | 1,224.06%254.44M | 34.90%163.62M | 105.64%26.18M | -302.72%-500.4M | 83.91%-22.64M | 144.64%121.29M |
| Add:Begin period cash and cash equivalents | 11.57%762.82M | 11.57%762.82M | 11.57%762.82M | -42.26%683.72M | -42.26%683.72M | -42.26%683.72M | -42.26%683.72M | 26.34%1.18B | 26.34%1.18B | 26.34%1.18B |
| End period cash equivalent | -63.48%342.57M | -47.94%441.09M | -13.90%611.25M | 11.57%762.82M | -19.23%938.16M | -35.09%847.34M | -1.40%709.9M | -42.26%683.72M | 45.81%1.16B | 96.14%1.31B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data